| 20739-9 |
Campylobacter sp |
Prid |
Body fld |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Campylobacter sp identified in Body fluid by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20739-9 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Campylobacter Fld Cult |
|
|
|
|
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Campy; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Spec; species; spp |
2.78 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 2074-3 |
Chloride |
SCnc |
Saliva |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Moles/volume] in Saliva (oral fluid) |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
2074-3 |
|
|
|
|
Both |
|
|
|
0 |
Chloride Sal-sCnc |
|
|
|
Y |
|
Chemistry; Cl; Cl-; Level; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration |
2.42 |
1 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 20740-7 |
Campylobacter sp |
Prid |
Tiss |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Campylobacter sp identified in Tissue by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20740-7 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Campylobacter Tiss Cult |
|
|
|
|
|
C&S; Campy; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Spec; species; spp; Tissue; Tissue, unspecified |
2.78 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 20741-5 |
Canarypox virus Ag |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Canarypox virus Ag [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20741-5 |
|
IF |
|
|
Both |
|
|
|
0 |
CNPV Ag Ser Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; CNPV; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20742-3 |
Canine distemper virus Ag |
PrThr |
Cnjt |
Pt |
Ord |
IF |
|
ACTIVE |
Canine distemper virus Ag [Presence] in Conjunctival specimen by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20742-3 |
|
IF |
|
|
Both |
|
|
|
0 |
CDV Ag Conjunct Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Canine distemper; CDV; Conjunct; Conjunctiva; Conjunctival; DFA; Dog; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Morbillivirus; Ordinal; Palpebral sac; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; TRF; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20743-1 |
Caprine arthritis encephalitis virus Ab |
ACnc |
Ser |
Pt |
Ord |
ID |
|
DEPRECATED |
Deprecated Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20743-1 |
|
ID |
|
|
|
|
|
|
0 |
Deprecated CAEV Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Arth; Autoantibodies; Autoantibody; CAE; CAEV; Caprine arthritis; Enc; Enceph; Encephalomyelitis; ID; Identifier; Infectious Disease; InfectiousDisease; Intradermal; Lentivirus; Microbiology; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 20744-9 |
Caprine arthritis encephalitis virus Ab |
ACnc |
Ser |
Pt |
Ord |
EIA |
|
DEPRECATED |
Deprecated Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20744-9 |
|
EIA |
|
|
|
|
|
|
0 |
Deprecated CAEV Ab Ser Ql EIA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Arth; Autoantibodies; Autoantibody; CAE; CAEV; Caprine arthritis; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Lentivirus; MEIA; Microbiology; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 20745-6 |
Carbamates |
PrThr |
Gast fld |
Pt |
Ord |
Screen |
|
ACTIVE |
Carbamates [Presence] in Gastric fluid by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20745-6 |
|
Screen |
|
|
Both |
|
|
|
0 |
Carbamates Gast Ql Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20746-4 |
Carbamates |
PrThr |
XXX |
Pt |
Ord |
Screen |
|
ACTIVE |
Carbamates [Presence] in Specimen by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20746-4 |
|
Screen |
|
|
Both |
|
|
|
0 |
Carbamates Spec Ql Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Spec; To be specified in another part of the message; Unspecified |
2.69 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20747-2 |
Carbamates |
PrThr |
Ingesta |
Pt |
Ord |
Screen |
|
ACTIVE |
Carbamates [Presence] in Ingesta by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20747-2 |
|
Screen |
|
|
Both |
|
|
|
0 |
Carbamates Ingesta Ql Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20748-0 |
Carbamates |
PrThr |
Tiss |
Pt |
Ord |
Screen |
|
ACTIVE |
Carbamates [Presence] in Tissue by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20748-0 |
|
Screen |
|
|
Both |
|
|
|
0 |
Carbamates Tiss Ql Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20749-8 |
Carbamates |
PrThr |
Feed |
Pt |
Ord |
Screen |
|
ACTIVE |
Carbamates [Presence] in Feed by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20749-8 |
|
Screen |
|
|
Both |
|
|
|
0 |
Carbamates Feed Ql Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 2075-0 |
Chloride |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
2075-0 |
|
|
|
|
Both |
|
|
|
0 |
Chloride SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Cl; Cl-; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 20750-6 |
Chicken anemia virus Ab.Neut |
PrThr |
Ser |
Pt |
Ord |
Neut |
|
ACTIVE |
Chicken anemia virus neutralizing antibody [Presence] in Serum by Neutralization test |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20750-6 |
|
Neut |
|
|
Both |
|
|
|
0 |
CAV NAb Ser Ql Nt |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Conventional virus neutralization test; cVNT; f083; f83; Gallus spp; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; Serum virus neutralization; SR; SVN; Vet; Veterinary; Virus neutralization test; VNT |
2.72 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20751-4 |
Chicken anemia virus Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Chicken anemia virus Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20751-4 |
|
IA |
|
|
Both |
|
|
|
0 |
CAV Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; EIA; ELFA; ELISA; Enzyme immunoassay; f083; f83; Gallus spp; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20752-2 |
Chlamydophila psittaci |
PrThr |
XXX |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Chlamydophila psittaci [Presence] in Specimen by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20752-2 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
C psittaci Spec Ql Cult |
|
|
|
|
|
Avian chlamydiosis; C psittaci; C&S; Chlamydia; Chlamydia psittaci; Chlamydial abortion; CPS; Cult; Cultures; Enzootic abortion of ewes; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Ornithosis; Other; Ovine chlamydiosis; Point in time; PR; Psittacosis; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20753-0 |
Chlamydophila psittaci Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Chlamydophila psittaci Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20753-0 |
|
IF |
|
|
Both |
|
|
|
0 |
C psittaci Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Avian chlamydiosis; C psittaci; Chlamydia; Chlamydia psittaci; Chlamydial abortion; CPS; DFA; Enzootic abortion of ewes; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Ornithosis; Ovine chlamydiosis; Point in time; PR; Psittacosis; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20754-8 |
Chlamydophila psittaci Ab |
PrThr |
Ser |
Pt |
Ord |
Comp fix |
|
ACTIVE |
Chlamydophila psittaci Ab [Presence] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20754-8 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
C psittaci Ab Ser Ql CF |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian chlamydiosis; C psittaci; CF; Chlamydia; Chlamydia psittaci; Chlamydial abortion; Comp fixation; Compfix; Complement fixation; CPS; Enzootic abortion of ewes; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Ornithosis; Ovine chlamydiosis; Point in time; PR; Psittacosis; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20755-5 |
Chlamydia sp Ag |
PrThr |
Body fld |
Pt |
Ord |
IA |
|
ACTIVE |
Chlamydia sp Ag [Presence] in Body fluid by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20755-5 |
|
IA |
|
|
Both |
|
|
|
0 |
Chlamydia Ag Fld Ql IA |
|
|
|
|
|
Antigen; Antigens; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chlam; Chlamid; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; SUDS |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20756-3 |
Chlamydia sp Ag |
PrThr |
Stool |
Pt |
Ord |
IA |
|
ACTIVE |
Chlamydia sp Ag [Presence] in Stool by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20756-3 |
|
IA |
|
|
Both |
|
|
|
0 |
Chlamydia Ag Stl Ql IA |
|
|
|
|
|
Antigen; Antigens; Bowel movement; Chlam; Chlamid; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; Stl; Stool = Fecal; SUDS |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20757-1 |
Chlamydia sp Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Chlamydia sp Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20757-1 |
|
IF |
|
|
Both |
|
|
|
0 |
Chlamydia Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Chlam; Chlamid; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20758-9 |
Cholinesterase |
CCnt |
Brain |
Pt |
Qn |
|
|
ACTIVE |
Cholinesterase [Enzymatic activity/mass] in Brain |
|
MIN |
DefinitionDescription |
|
|
U/g Hb |
|
|
|
|
|
|
CHEM |
|
20758-9 |
|
|
|
|
Both |
|
|
|
0 |
Cholinesterase Brain-cCnt |
|
|
|
Y |
|
Acylcholine acylhydrolase; BChE; Benzoyl cholinesterase; Benzoylcholinesterase; Butyrylcholine esterase; Catalytic Content; Cerebral; Cerebrum; Che; Chemistry; Choline esterase II; CHS; Head; Intracranial; Point in time; Pseudocho; Pseudocholinesterase; QNT; Quan; Quant; Quantitative; Random |
2.4 |
1.0m |
|
|
|
|
|
|
|
U/g{Hb} |
|
|
|
0 |
| 20759-7 |
Chromium |
MCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Chromium [Mass/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
ug/g |
|
|
|
|
|
|
DRUG/TOX |
|
20759-7 |
|
|
|
|
Both |
|
|
|
0 |
Cr Tiss-mCnt |
|
|
|
Y |
|
c609; Chrome; CR; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified |
2.75 |
1.0m |
|
|
|
|
|
|
|
ug/g |
|
|
|
0 |
| 2076-8 |
Chloride |
SCnt |
Stool |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Moles/mass] in Stool |
|
MIN |
DefinitionDescription |
|
|
mmol/kg |
|
|
|
|
|
|
CHEM |
|
2076-8 |
|
|
|
|
Both |
|
|
|
0 |
Chloride Stl-sCnt |
|
|
|
Y |
|
Bowel movement; Chemistry; Cl; Cl-; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Content |
2.73 |
1 |
|
|
|
|
|
|
|
mmol/kg |
|
|
|
0 |
| 20760-5 |
Clostridium chauvoei Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Clostridium chauvoei Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20760-5 |
|
IF |
|
|
Both |
|
|
|
0 |
C chauvoei Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; C chauvaei; C chauvoei; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
